Home / Transcripts / Microvast Holdings, Inc. (MVST) · November 9, 2026

Microvast Holdings, Inc. (MVST) Earnings Call Transcript

November 9, 2026

NASDAQ US Industrials Machinery earnings 19 min

Earnings Call Speaker Segments

Rodney Worthen executive
#1

Thanks, operator, and I appreciate everyone joining us for today's update. This is Rodney Worthen, Microvast's Chief Financial Officer, and with me on today's call is Mr. Yang Wu, our Founder, Chairman, and Chief Executive Officer of Microvast. I'll start by going over the third quarter results, and after that I'll turn the call over to Mr. Wu for operational and business updates. Earlier today, before this call, Microvast released its third quarter earnings press release, which is available in the Investor Relations section of our website, ir.microvast.com. A slide presentation has also been posted that accompanies management's prepared remarks for today's call. As a reminder, please be aware that forward-looking statements may be included in this call. These remarks reflect what we currently expect and assume, and you shouldn't treat them as standing in for our views on any later date. We're not committing to update or publish any revised version of these forward-looking statements, whether because of fresh information or later developments. A range of risks and uncertainties could cause actual results to come in materially different from what we expect; to learn more about the material risks and other significant factors that might influence our financial results — including substantial doubt and our capacity to keep operating as a going concern — please see the documents we file with the SEC, among them our quarterly report on Form 10-Q covering the quarter that ended September 30, 2026. During this call we may also talk about non-GAAP financial measures. Keep in mind that you should view these metrics alongside GAAP figures rather than as a replacement for them or on a standalone basis. Reconciliations of each non-GAAP measure to the closest corresponding GAAP metric appear in the tables at the back of our earnings press release and slide deck. Once this call wraps up, a replay of the webcast can be accessed through the Investor Relations portion of Microvast's website. At this point, please turn with me to Slide 3, where we break down our third quarter results across the last several years. Revenue for the quarter came in at a decrease of $77.5 million, or 62.8%, relative to the same period in 2025. That drop mostly comes from a 62.2% fall in sales volume — roughly 502 megawatt hours in Q3 2025 down to about 190 megawatt hours in the same period of 2026. Sales came in weaker throughout Europe and APAC because end-market demand softened for heavy trucks, port equipment, and heavy mining equipment, and that cut orders from a number of our long-standing customers in both Europe and APAC. Commercial vehicle regulations and geopolitical shifts that keep evolving — the Indian and Korean markets among them — along with a shift in India toward lower-cost products, went on weighing on demand. US sales fell year over year, largely because our biggest customer pulled forward purchases of 2025 product amid tariff-related uncertainty. Cost of revenues for the quarter declined $38.1 million, or 52.7%, from the same period in 2025, chiefly on lower sales volume. Gross profit margin for the quarter was 5.2%, compared with 37.6% in 2025. The change stemmed mostly from a $9.3 million write-down of obsolete inventories related to specialized BESS components and other inventories, which reduced our gross margin by 20.4 percentage points. Once you set aside that non-cash charge, the lower gross margins came from the substantial drop in sales volume along with persistent pricing pressure within the lithium battery industry. Revenue coming down also meant we absorbed less of our fixed manufacturing and operating costs, which squeezed gross margin further. Our gross margin profile faces outside pressures, among them inflationary trends in raw material pricing, duties, taxes, and tariffs, plus elevated logistic and freight expenses stemming from continuing global supply chain disruptions and geopolitical conflicts. Effective September 1, 2026, China has put a 2% consumption tax on lithium battery products sold in China, and that tax will rise to 4% effective September 1, 2027. China additionally lowered the VAT export rebate for certain lithium battery products, taking it down from 9% to 6%, with that change taking effect on April 1, 2026, and the rebate is set to disappear entirely starting January 1, 2027. We continue to work on ways to reduce costs, but those broader economic forces, along with the gradual removal of regional incentives for EV purchases, have created a tough backdrop for short-term profitability throughout the battery manufacturing industry. Slide 4 covers our P&L for both the quarter and the year to date. Turning now to operating expenses in the quarter, they climbed to $69 million, up from $31.6 million in 2025 — a year-over-year jump of 118.8%. G&A costs came in $2.6 million higher this quarter versus the same stretch in 2025 — a 14.7% increase — driven primarily by a $5.1 million litigation settlement provision. The company's insurance policy limits total retention to $10 million, its self-insured retention, with the rest of the costs and fees, including whatever remains of any proposed settlement, expected to be picked up by the insurer. By September 30, 2026, the company had paid $4.9 million against that self-insured retention and accrued the other $5.1 million. That said, we can't guarantee the court will sign off on the proposed settlement, or that it will close under the terms we've described—or close at all. You can find more detail in Note 16, Commitments and Contingencies, in our Form 10-Q. R&D costs rose $605,000, or 7.8%, versus the same quarter in 2025, driven primarily by higher labor costs as we deepened investment in new product development. Selling and marketing expenses fell $1.4 million, or 23.9%, compared with the same period in 2025, largely because of lower personnel costs. On top of that, we had non-cash impairment charges on long-lived assets totaling $35.7 million this quarter, mostly from impairment losses of $15 million, $4.4 million, and $16.3 million on our operations in China, Germany, and the US, respectively. That impairment figure came out of impairment testing across all production line assets and construction in progress assets, which the sharp drop in sales, gross margin, and operating performance in Q3 2026 set off. For the quarter, we posted a GAAP net loss of $76.8 million. Once we adjust for non-cash items like $0.8 million in stock-based compensation, our adjusted net loss came to $76 million, versus an adjusted net profit of $11.9 million a year earlier. For Q3 2026, non-GAAP adjusted EBITDA came in at negative $60.8 million, whereas Q3 2025 posted $21.9 million. Across the nine-month span, revenues dropped $137.4 million, a 41.5% decrease relative to the comparable 2025 period. The primary factor was a 37.4% fall in sales volume, going from about 1,449 megawatt hours during the nine months ended 2025 to about 907 megawatt hours in the same period of 2026. Gross profit margin over those nine months stood at 24.4%, compared with 36.6% in 2025. That change largely reflected $11.1 million of write-downs on obsolete inventories associated with specialized BESS components as well as other inventories, which reduced our gross margin by 5.7 percentage points.

Rodney Worthen executive
#2

Excluding that non-cash charge, the gross margin decline stems from a steep falloff in sales volume, geographic mix shifts, and persistent pricing pressure in the lithium battery sector. Because revenue dropped so substantially, we spread our fixed and operating costs over fewer sales, putting additional pressure on gross margin. The revenue and gross margin decreases for the year-to-date period come from the same drivers I cited for the quarter, along with $2.7 million of tariff refunds paid to US customers, which we booked as a revenue reduction this period. Operating expenses for the year-to-date period climbed to $123.6 million, up from $84.4 million in 2025 — a 46.5% year-over-year increase. G&A costs across the nine months climbed $4.1 million, or 9.6%, versus the corresponding stretch of 2025. Driving that were a $5.1 million litigation settlement provision, $684,000 more in share-based compensation, and $976,000 higher insurance fees — partially offset by labor costs falling $1.3 million and a $2.7 million drop in the credit loss allowance stemming from better credit management. R&D spending over the nine months was up $2.3 million, or 9.7%, against the same period in 2025. That growth came largely from a $2 million increase in labor costs tied to our expanding investment in new product development. For the nine-month period, selling and marketing expenses dropped $1.6 million, or 9.7%, versus the same stretch in 2025. The main driver of that decline was a $1.4 million reduction in labor costs. Non-cash impairment charges tied to long-lived assets came to $35.8 million across the nine months, largely reflecting impairment losses of $15.1 million in China, $4.4 million in Germany, and $16.3 million in the US. We posted a GAAP net loss of $40.6 million for the nine-month period. On a non-GAAP adjusted basis, the net loss for the nine months was $96 million, compared with non-GAAP adjusted net profit of $47.5 million a year earlier. On a non-GAAP basis, adjusted EBITDA came in at negative $62.7 million, versus $76.3 million of non-GAAP adjusted EBITDA a year earlier. You can find reconciliations from non-GAAP metrics to the closest GAAP equivalents in the tables at the back of our slide presentation and in our earnings press release. If you'll move to Slide 5, we'll go through revenue by region. US sales were down compared with a year ago, largely because our biggest customer pulled product in from 2025 given uncertainty over how tariffs would play out. For the quarter, US revenue totaled $4.5 million, down 31% from $6.6 million in the same period last year. Over the nine-month stretch, revenue in the US totaled $3 million, down 83% from $17.8 million a year earlier, partly because of a $2.7 million cut tied to tariff refunds in Q2. Excluding that reduction, US revenue across the nine months would have been $5.7 million. In the quarter, European sales reached $27.8 million, a 64% drop from 77.9% in the comparable period last year. That region accounted for 60% of quarterly revenue, versus 64% a year ago. Year to date, sales declined 30% to $123.5 million, compared with $176.8 million in the prior year period. The decline came from softer demand in end markets, and that led a number of long-time customers in the region to reduce what they ordered. APAC revenue for the quarter came to $13.5 million, a 65% decrease from $38.8 million in the same period a year earlier. Sales for the year to date fell 51%, landing at $67.2 million versus $136.5 million in the prior-year period. In addition to the weaker end-market demand and the lower orders from long-standing customers we discussed earlier, APAC demand continued to be pressured by changing commercial vehicle regulatory and geopolitical dynamics, including in the Indian and Korean markets, along with demand shifting toward lower-cost products in India. Turning now to Slide 6, we'll walk through cash flow for the year to date. Operating activities consumed $65.4 million in net cash across the nine months, whereas the same stretch in 2025 produced $59.5 million in cash from operations. The swing came primarily from a $105.1 million drop in net income once non-cash items were adjusted for, plus a $19.8 million net movement in operating assets and liabilities. That movement stemmed mostly from lower notes payable, reduced accrued expenses and other liabilities, and a larger inventory balance, partially offset by a smaller accounts receivable figure resulting from better credit management. Investing activities consumed $5.6 million in net cash across the nine months, versus $15.5 million during the corresponding stretch of 2025. Breaking that outflow down, $9.2 million went toward buying an office building in Houston, and $7.3 million covered machinery and equipment purchases plus other capital expenditures related to expanding our Huzhou Phase 3.2 manufacturing facility; those amounts were partially offset by $10.8 million in proceeds from the sale of our Lake Mary, Florida facility, which prior to disposal had been classified as held-for-sale assets. Financing activities produced $23.3 million in net cash over the nine months, a $32.8 million increase compared with the $9.5 million used in the same period in 2025. That gain came mainly from a $25.7 million increase in money received via bank borrowings, along with a $10.9 million reduction in deferred payment tied to purchases of property, plant, and equipment, as most of those were paid off in the first quarter of 2026 — partially offset by a $6.1 million rise in bank borrowing repayments. Once a $3 million foreign exchange adjustment is factored in, cash, cash equivalents, and restricted cash fell by $44.8 million, leaving us at $124.4 million in cash, cash equivalents, and restricted cash at quarter's end. I'll now turn things over to Mr. Wu for operational and business updates.

Yang Wu executive
#3

Thank you. As the details of our financial results show, the third quarter brought a very difficult operating climate for Microvast; we worked through weaker demand for commercial vehicles in our main markets of Europe and the Asia-Pacific region, and that was made worse by continuing pricing pressure across the industry. Those prolonged macroeconomic headwinds produced a substantial drop in our revenue and operating performance, yet our team is sharply focused on the factors we can control: containing costs, safeguarding our liquidity, tackling our sizable near-term debt maturities, and pushing forward our strategic production milestones. On the manufacturing roadmap, installation and commissioning of the Phase 3.2 production equipment at our Huzhou, China facility are now finished. The pace at which we can increase output depends on several factors: what customers require, how well production yields perform, qualification of products, efficiency in operations, and whether working capital is available. If production volumes don't rise substantially, the Phase 3.2 line will operate below its designed capacity. At our Clarksville facility in the United States, the pack assembly line is essentially finished. Resuming full-scale construction there is still contingent on securing additional financing and strategic partnerships. Now, I'd like to go over a few of our recent research and development updates. Please turn with me to Slide 8. Despite the financial challenges, we continue to make steady progress in research and development. While these technologies remain in development, lab findings alone don't prove we're commercially ready. In the solid-state program, we've advanced our liquid-free architecture. In the lab, a 17-layer bipolar prototype delivered roughly 72 volts and reached 366 watt-hours per kilogram in specific energy. In longer testing, a long-cycle development cell held more than 79.5% of its capacity past 1,300 cycles at 0.3C. Our solid-state battery sits at the early prototype stage today. What I've just shared is preliminary R&D data, drawn from separate prototypes and gathered under limited lab or test conditions. Those aren’t commercial qualification results, and they still depend on additional validation, repeated testing, scaling up, customer qualification, manufacturing readiness, and available capital. Also, on Slide 9, we’re moving our silicon-sulfur chemistry forward as well. In our first lab prototypes, a sulfur-based cathode is combined with a pre-lithiated silicon-based anode. A five-layer bipolar prototype study showed that during discharge, the cathode’s expansion is partly offset by contraction of the anode. We’re assessing this internal dimensional compensation as a possible route toward monolithic integration in higher-voltage solid-state assemblies. Our silicon-sulfur chemistry is still at the early lab prototype stage right now, and those results are likewise preliminary and will need the same additional validation, testing, scale-up, qualification, and manufacturing readiness and capital requirements. Please turn to Slide 10. With uncertainty surrounding our liquidity position, our continuing talks with our lender about refinancing, extending, or restructuring our near-term debt obligations, and softer demand in end markets, our near-term priorities focus on controlling costs, preserving liquidity, addressing our significant near-term debt maturity, and stabilizing our operations. We're implementing operating cost reduction initiatives across every part of the business, scaling back and postponing some discretionary capital expenditures, and carrying out targeted workforce reductions at certain of our operations. The cost-cutting initiative we launched still isn't fully in place, and the cash expenses associated with it have strained our liquidity in the near term and could continue to do so. While working to steady the business, we are examining all possible avenues for improving our liquidity position, asset divestitures among them, and we are talking with our lenders about refinancing, extending, or restructuring the debt obligations coming due soon. We cannot guarantee that those talks will be successful. We continue to look for potential near-term openings in the commercial vehicle market. Our team is working hard to steer through this difficult worldwide macroeconomic climate, and we remain committed to carrying out our updated business plan so that our liquidity is protected. We can’t guarantee those efforts will work. As we disclosed in our Form 10-Q, the significant uncertainty about whether we can keep operating as a going concern is still unresolved. We appreciate your ongoing backing and expect to provide more updates over the coming months.

Operator operator
#4

The conference operator here — that brings the webcast to a close. Thanks for being with us on Microvast's third quarter 2026 earnings call. You're welcome to disconnect at this time.

For developers and AI pipelines

Programmatic access to Microvast Holdings, Inc. earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.